egov.mn

Alcohol cut the survival gain from immunotherapy in half in mice with lung cancer

Alcohol may seriously reduce the effectiveness of cancer immunotherapy, according to new research. A study...

This story was prepared automatically by software.

Alcohol cut the survival gain from immunotherapy in half in mice with lung cancer

Alcohol may seriously reduce the effectiveness of cancer immunotherapy, according to new research. A study published in Science Signaling found that moderate-to-heavy alcohol consumption reduced the effectiveness of cancer drugs by approximately 50 percent in mice with lung and bladder cancer.

These drugs are “immune checkpoint inhibitors (ICIs),” so they help the immune system recognize and attack cancer cells. Turns out, alcohol might dull more than just our senses. Regular drinking was associated with reduced survival benefits among lung cancer patients receiving immunotherapy.

“The findings together suggest that regular alcohol use can impair the efficacy of ICI against cancer,” the researchers wrote.

Alcohol and cancer treatment

Immune checkpoint inhibitors help the immune system attack cancer by blocking proteins that restrict immune cell activity.

One treatment, anti-PD1 immunotherapy, targets a protein called programmed cell death protein 1. These treatments have improved outcomes for patients with advanced cancers, but fewer than 30 percent achieve a durable response across most tumor types, according to the study.

“By defining how modifiable risk factors affect ICI response, recommendations can be established to improve the likelihood of durable response to ICI,” the researchers wrote.

To investigate these effects, researchers gave mice moderate or heavy amounts of ethanol for five weeks before introducing lung or bladder cancer cells. Then, researchers gave the mice immunotherapy while monitoring tumor growth, survival, and recurrence.

In mice with lung cancer, immunotherapy extended median survival from approximately 30 to 86 days without alcohol exposure. With alcohol exposure, median survival was 58 days. In the mice with bladder cancer, immunotherapy increased survival from 22.2 percent to 88.9 percent, but alcohol reduced survival to below 30 percent.

“In both models, ethanol did not affect survival in the absence of ICI, indicating a disruption of antitumor immunity,” the researchers wrote.

Humans showed similar patterns

The researchers then turned to medical records. They examined patients who received anti-PD1 treatment at the University of North Carolina at Chapel Hill Cancer Hospital between 2014 and 2018.

Patients were classified as occasional drinkers, consuming less than one drink weekly, or regular drinkers, averaging about eight drinks per week. Among 93 lung cancer patients, regular alcohol consumption was significantly associated with reduced survival following immunotherapy.

Findings for bladder cancer were less conclusive. Researchers found no significant effect on survival after treatment began among patients with melanoma or head and neck cancer.

Alcohol weakens immune system

Further experiments revealed that alcohol reduced the number of T cells entering tumors and impaired the activity of CD8+ T cells, which help destroy cancer cells. Alcohol exposure also increased the presence of TIGIT, a protein that inhibits immune cell activity.

Researchers tested whether blocking TIGIT alongside PD1 could improve treatment outcomes.

In alcohol-exposed mice, combining anti-PD1 therapy with antibodies targeting TIGIT restored treatment responses to nearly those observed in mice without alcohol exposure. Complete tumor responses reached 55.5 percent in alcohol-exposed mice receiving the combination, compared with 60 percent in controls.

The researchers emphasized that their human analysis was limited by small patient samples, incomplete alcohol consumption records, and insufficient tumor immune data. They called for prospective clinical studies to determine how drinking frequency and quantity affect outcomes across different cancers.

But already, the findings suggest that regular alcohol consumption can interfere with cancer immunotherapy and that TIGIT could improve treatment effectiveness.

Source: https://interestingengineering.com/research/alcohol-cut-the-survival-gain-from-immunotherapy

Share
Next story6-million-year-old whale may have had the most asymmetrical face ever seen in mammals
Newsletter

Get the latest news delivered to your inbox.

Related articles